Clinical trial NCT01291121 - References

Neovascular Age-related Macular Degeneration — Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion

Citation(s)

•   Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ
  Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006 Mar;113(3):363-372.e5. Epub 2006 Feb 3.
•   Brantley MA Jr, Edelstein SL, King JM, Plotzke MR, Apte RS, Kymes SM, Shiels A
  Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy. Eye (Lond). 2009 Mar;23(3):626-31. doi: 10.1038/eye.2008.28. Epub 2008 Feb 22.
•   Brantley MA Jr, Fang AM, King JM, Tewari A, Kymes SM, Shiels A
  Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. Ophthalmology. 2007 Dec;114(12):2168-73.
•   Freeman WR, Falkenstein I
  Avastin and new treatments for AMD: where are we? Retina. 2006 Oct;26(8):853-8. Review.
•   Goverdhan SV, Hannan S, Newsom RB, Luff AJ, Griffiths H, Lotery AJ
  An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment. Eye (Lond). 2008 Jun;22(6):849-54. Epub 2007 Apr 27.
•   Klein R, Peto T, Bird A, Vannewkirk MR
  The epidemiology of age-related macular degeneration. Am J Ophthalmol. 2004 Mar;137(3):486-95. Review.
•   Krebs I, Brannath W, Glittenberg C, Zeiler F, Sebag J, Binder S
  Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? Am J Ophthalmol. 2007 Nov;144(5):741-746. Epub 2007 Sep 20.
•   Lee SJ, Koh HJ
  Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration. Ophthalmology. 2011 Jan;118(1):101-10. doi: 10.1016/j.ophtha.2010.04.015. Epub 2010 Aug 3.
•   Lee SJ, Lee CS, Koh HJ
  Posterior vitreomacular adhesion and risk of exudative age-related macular degeneration: paired eye study. Am J Ophthalmol. 2009 Apr;147(4):621-626.e1. doi: 10.1016/j.ajo.2008.10.003. Epub 2009 Jan 20.
•   Lux A, Llacer H, Heussen FM, Joussen AM
  Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions. Br J Ophthalmol. 2007 Oct;91(10):1318-22. Epub 2007 May 30.
•   Mojana F, Cheng L, Bartsch DU, Silva GA, Kozak I, Nigam N, Freeman WR
  The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. Am J Ophthalmol. 2008 Aug;146(2):218-227. doi: 10.1016/j.ajo.2008.04.027. Epub 2008 Jun 6.
•   Ondes F, Yilmaz G, Acar MA, Unlü N, Kocaoglan H, Arsan AK
  Role of the vitreous in age-related macular degeneration. Jpn J Ophthalmol. 2000 Jan-Feb;44(1):91-3.
•   Quaranta-El Maftouhi M, Mauget-Faÿsse M
  Anomalous vitreoretinal adhesions in patients with exudative age-related macular degeneration: an OCT study. Eur J Ophthalmol. 2006 Jan-Feb;16(1):134-7.
•   Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY; MARINA Study Group
  Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 5;355(14):1419-31.

Intravitreal Administration of Ranibizumab Combined With Intravitreous Injection of Expansile Gas and Induction of Posterior Vitreous Detachment in Treatment of Exudative AMD With Posterior VMA: a Pilot, Open Label, Comparative Study

Details for clinical trial NCT01291121